Universal Vision Biotechnology Co., Ltd.
3218
Rank in Stocks
#14418
Universal Vision Biotechnology Co., Ltd., established in 1992 and based in... Universal Vision Biotechnology Co., Ltd., established in 1992 and based in Taipei, Taiwan, manages a network of eye care clinics across both Taiwan and China. The company delivers a comprehensive range of ophthalmic services, encompassing advanced surgical interventions and treatments for various ocular conditions. Its surgical specialties include laser vision correction for common refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related vision decline). They also perform intraocular lens procedures for presbyopia and cataracts, employing advanced techniques like phacoemulsification and femtosecond laser surgery. Beyond surgical solutions, Universal Vision addresses a wide spectrum of eye health concerns, offering services for myopia control, dry eye syndrome, retinal detachment, macular degeneration, strabismus (crossed eyes), amblyopia (lazy eye), and numerous other ophthalmic ailments. The company further provides a diverse array of vision products and optical aids, including various eyeglass frames, specialized multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, and both conventional and colored contact lenses. Nutritional eye supplements are also available. Additional offerings include oculoplastic and micro cosmetic eye surgery, alongside bespoke aesthetic medicine consultations. Furthermore, Universal Vision engages in optometric services, hospital administration, technical advisory roles, and the distribution and rental of medical equipment.
Share Price
$3.84
Last synced: 2026-11-10
Market Cap
$325.43M
Change (1 day)
1.20%
Change (1 year)
-14.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Universal Vision Biotechnology Co., Ltd. (3218)
Category
Healthcare
EPS for Universal Vision Biotechnology Co., Ltd. (3218)
EPS as of June 2026 TTM: $0.42
According to Universal Vision Biotechnology Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.42. At the end of 2025 the company had an EPS of $0.39, an increase over its 2024 EPS of $0.38.
EPS history for Universal Vision Biotechnology Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.42 | 6.95% |
| 2025 | $0.39 | 2.24% |
| 2024 | $0.38 | -4.62% |
| 2023 | $0.40 | 22.85% |
| 2022 | $0.33 | 29.10% |
| 2021 | $0.25 | 24.80% |
| 2020 | $0.20 | 116.40% |
| 2019 | $0.09 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | 7,157.25% |
US
|
|
| $3.19 | 664.66% |
DE
|
|
| $34.71 | 8,221.75% |
US
|
|
| $1.90 | 356.05% |
SA
|
|
| $0.29 | -30.95% |
CN
|
Questions about Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS)
What is Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS)?
Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.42, as of Jun 2026.
What was Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) was $0.39, 2.63% more than in 2024 ($0.38).
How has Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) went from $0.20 to $0.39, an average growth of 14.29% a year.
How does Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Universal Vision Biotechnology Co., Ltd.'s earnings per share (EPS) ($0.42) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.